Elafin (TG3) - Revision history

Bernadett at 12:03, 10 March 2015

2015-03-10T12:03:09Z

WikiSysop at 12:30, 14 September 2007

2007-09-14T12:30:57Z

193.6.138.71 at 13:19, 4 September 2007

2007-09-04T13:19:59Z

WikiSysop at 08:08, 4 September 2007

2007-09-04T08:08:35Z

WikiSysop at 15:21, 17 August 2007

2007-08-17T15:21:02Z

WikiSysop at 11:25, 25 July 2007

2007-07-25T11:25:55Z

WikiSysop: New page: {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | align="center" colspan="2...

2007-07-25T05:35:35Z

New page: {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | align="center" colspan="2...

New page

{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
! {{infobox header}}| '''{{PAGENAME}}'''
|-
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
|-
| Substrate peptide name
| {{PAGENAME}}
|-
| Synonyms
| Cementoin
Elastase-specific inhibitor
|-
| Determination type
| In situ/In vitro
|-
| Source
| Homo sapiens
|-
| Subcellular localization
| Cornified evelope
|-
| Swissprot ID
| [http://au.expasy.org/uniprot/P19957 P19957 ]
|-
| Reactive glutamines
| [[Q2 Q59 (Elafin)|Q2 Q59]]
|-
| Reactive lysines
| [[K6 (Elafin)|K6]]
|-
| Substrate sequence
| A''Q''EPV''K''GPV

ACFVP''Q''

|-
| Structure
| [http://www.rcsb.org/pdb/explore/explore.do?structureId=2REL 2REL]
|-
| Surface accessibility
| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
|-
| Disorder prediction
| [http://iupred.enzim.hu/index.html IUPred]
|-
| Reference
| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=7543090&dopt=Abstract PMID:7543090]
|-
| Notes
|
|-
| {{infobox header}} |
|-
|}

[[Category:Epidermal transglutaminase|*]]

@@ Line 52: / Line 52: @@
 |-
 | Video
-|{{#ev:youtube|aahV6pBrOD4|100}}
+|{{#ev:dailymotion|ot2lRay5hDTBDkXRI|300}}
 |-
 | {{infobox header}} |

@@ Line 1: / Line 1: @@
 {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
-! {{infobox header}}| '''{{PAGENAME}}'''
+! {infobox header}| '''{{PAGENAME}}'''
 |-
 | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Elafin.JPG|200px|{{PAGENAME}}]]
@@ Line 54: / Line 54: @@
 |{{#ev:dailymotion|ot2lRay5hDTBDkXRI|300}}
 |-
-| {{infobox header}} |
+| {infobox header} |
 |-
 |}
 [[Category:Epidermal transglutaminase|*]]

@@ Line 2: / Line 2: @@
 ! {{infobox header}}| '''{{PAGENAME}}'''
 |-
-| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
+| align="center" colspan="2" bgcolor="#ffffff" | [[Image:Elafin.JPG|200px|{{PAGENAME}}]]
 |-
 | Substrate peptide name
@@ Line 50: / Line 50: @@
 | Notes
+|
 |-
 | {{infobox header}} |

@@ Line 24: / Line 24: @@
 |-
 | Reactive glutamines
-| [[Q2 Q59 (Elafin)|Q2 Q59]]
+| [[TG2 reactive residues (Elafin)|Q2 Q59]]
 |-
 | Reactive lysines
-| [[K6 (Elafin)|K6]]
+| [[TG2 reactive residues (Elafin)|K6]]
 |-
 | Substrate sequence

@@ Line 5: / Line 5: @@
 |-
 | Substrate peptide name
-| {{PAGENAME}}
+| Elafin
 |-
 | Synonyms

@@ Line 39: / Line 39: @@
 |-
 | Surface accessibility
-| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
+| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2rel.pdf ASAView] pdf
 |-
 | Disorder prediction